Stephens Inc’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,406
Closed -$396K 1300
2025
Q1
$396K Buy
5,406
+1,875
+53% +$155K 0.01% 894
2024
Q4
$292K Sell
3,531
-698
-17% -$55.1K ﹤0.01% 1025
2024
Q3
$303K Buy
4,229
+138
+3% +$9.74K ﹤0.01% 1019
2024
Q2
$280K Buy
4,091
+20
+0.5% +$1.2K ﹤0.01% 1035
2024
Q1
$218K Buy
4,071
+626
+18% +$33.7K ﹤0.01% 1130
2023
Q4
$184K Sell
3,445
-463
-12% -$22.6K ﹤0.01% 1101
2023
Q3
$194K Buy
+3,908
New +$219K ﹤0.01% 1048

Other funds holding GMED

Stephens Inc's GMED Position: Q2 2025 in Review

Stephens Inc sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 5,406 shares — an estimated $396K sold.

Stephens Inc first reported a position in GMED in Q3 2023 and held it in 7 quarters. The position peaked at $396K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Stephens Inc reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Stephens Inc sold 5,406 Globus Medical shares in Q2 2025, an estimated $396K.
  • Stephens Inc first reported a position in Globus Medical in Q3 2023 and held it in 7 quarters.
  • Stephens Inc's Globus Medical position peaked at $396K in Q1 2025.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Stephens Inc's 13F filing for Q2 2025, filed 29 Jul 2025.